Bingyang Xu

414 total citations
20 papers, 279 citations indexed

About

Bingyang Xu is a scholar working on Dermatology, Pharmacology and Immunology. According to data from OpenAlex, Bingyang Xu has authored 20 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 5 papers in Pharmacology and 4 papers in Immunology. Recurrent topics in Bingyang Xu's work include Acne and Rosacea Treatments and Effects (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Particle Dynamics in Fluid Flows (3 papers). Bingyang Xu is often cited by papers focused on Acne and Rosacea Treatments and Effects (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Particle Dynamics in Fluid Flows (3 papers). Bingyang Xu collaborates with scholars based in China, Russia and Sweden. Bingyang Xu's co-authors include Jia Sun, Dawei Ye, Ya‐Qun Zhou, Danyang Li, Jiayan Li, Long-Qing Zhang, Shuang Zhang, Jiayi Wu, Wei Mei and Shao‐Jie Gao and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Immunology and Fuel.

In The Last Decade

Bingyang Xu

18 papers receiving 274 citations

Peers

Bingyang Xu
Comparison fields: 5 of 101
  • Molecular Biology 67
  • Physiology 47
  • Immunology 43
  • Infectious Diseases 41
  • Epidemiology 39
Replace Weifeng Yao with:
Weifeng Yao China
Xiaoxia Duan China
Thibault Teissier France
Mariana Dupont United States
Giselle Santos Magalhães Brazil
Hongbin Hu China
R. Hilge Germany
Sawako Goto Japan
Weifeng Yao China View profile →
Citations per field, relative to Bingyang Xu
Bingyang Xu · 1×
Citations per year, relative to Bingyang Xu
Bingyang Xu · 1×

Countries citing papers authored by Bingyang Xu

Since Specialization
Citations

This map shows the geographic impact of Bingyang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyang Xu more than expected).

Fields of papers citing papers by Bingyang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyang Xu. The network helps show where Bingyang Xu may publish in the future.

Co-authorship network of co-authors of Bingyang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bingyang Xu. A scholar is included among the top collaborators of Bingyang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingyang Xu. Bingyang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 0
3 1
4 2
5 5
6 3
7 8
8 3
9 13
10 1
11 22
12 27
13 61
14
Nox2 contributes to reactive oxygen species-induced redox imbalance in cancer-induced bone pain.
7
15 73
16 17
17 10
18 0
19 14
20 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026